PT - JOURNAL ARTICLE AU - Charles Hart AU - Erin Hassett AU - Chantal B.F. Vogels AU - Daniel Shapley AU - Nathan D. Grubaugh AU - Saravanan Thangamani TI - First detection of Powassan Virus lineage I in field-collected <em>Dermacentor variabilis</em> from New York, USA AID - 10.1101/2022.03.01.22271704 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.01.22271704 4099 - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271704.short 4100 - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271704.full AB - Powassan virus (POWV) is a tick-borne flavivirus that can cause lethal or debilitating neurological illness. It is canonically transmitted by Ixodes genus ticks but may interact with sympatric Dermacentor species. Here, we report the first detection of POWV lineage I from a pool of field-collected D. variabilis in New York state.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study described in this manuscript was funded by Departmental Start-up funds, Upstate Foundation (Fund ID: 23709) and SUNY Empire Innovation Professorship funds to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.